BIOA vs KEYS · rev $9.0M vs P/E 57, rev $4.98B
BioAge Labs, Inc (BIOA) versus Keysight Technologies Inc (KEYS) — a side-by-side from cached financials, not a winner call.
BioAge Labs, Inc (BIOA) is a drug manufacturers - specialty & generic company listed on US.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Latest reported BIOA revenue for 2025-12-31 was $9.0M. Net income was -$80.6M. BIOA currently screens at market cap $697.9M.
Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
BIOA currently screens at market cap $697.9M. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Not investment advice. Open the BIOA and KEYS stock pages for the full models.
Not investment advice.